Page last updated: 2024-10-29

ketoprofen and Triple Negative Breast Neoplasms

ketoprofen has been researched along with Triple Negative Breast Neoplasms in 2 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research Excerpts

ExcerptRelevanceReference
"Ketoprofen is a Non-steroidal anti-inflammatory drug (NSAID) with anti-tumor properties."1.91Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy. ( Ahmad, I; Awadh, SA; Hamad, DA; Hameed, NM; Hussam, F; Kadhim, MM; Mustafa, YF; Naser, RH; Parra, RMR; Patra, I, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Patra, I1
Naser, RH1
Hussam, F1
Hameed, NM1
Kadhim, MM1
Ahmad, I1
Awadh, SA1
Hamad, DA1
Parra, RMR1
Mustafa, YF1
Ma, ZY1
Song, XQ1
Hu, JJ1
Wang, DB1
Ding, XJ1
Liu, RP1
Dai, ML1
Meng, FY1
Xu, JY1

Other Studies

2 other studies available for ketoprofen and Triple Negative Breast Neoplasms

ArticleYear
Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy.
    Molecular biology reports, 2023, Volume: 50, Issue:1

    Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Janus Kinases; Ketoprofen; Signa

2023
Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment.
    Biochemical pharmacology, 2021, Volume: 188

    Topics: A549 Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cisplatin; Epit

2021